Anti-SARS-CoV2 orf7b antibody [EPR26296-89]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal NS7B antibody. Suitable for I-ELISA and reacts with SARS-CoV-2 samples.
View Alternative Names
ORF7b protein, ORF7b, Accessory protein 7b, 7b
- I-ELISA
Supplier Data
Indirect ELISA - Anti-SARS-CoV2 orf7b antibody [EPR26296-89] (AB322903)
Human orf7b concentration was interpolated from the orf7b standard curve. Samples were serially diluted and assessed by the Rabbit Monoclonal to SARS-CoV2 orf7b (ab322903). Orf7b immunogen and non-immunogen peptide, and Recombinant SARS-CoV-2 ORF7B Protein were assessed in duplicate (n=2). Data are represented as the mean and error bars represent standard deviation.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com